Meno Swiss
Tackling a Silent Crisis: Increasing Health and Productivity of Women Ages 40–50 in Switzerland
Context
Perimenopause is a natural but underrecognized phase affecting women typically between ages 40 and 50. In Switzerland, around 680,000 women are in this age group and many experience fatigue, anxiety, mood changes or sleep disturbances without realizing these are early symptoms of perimenopause. Without proper understanding and support, this menopause transition phase can lead to long-term health issues such as cardiovascular disease, osteoporosis and depression, while affecting life quality and productivity. Meno Swiss addresses this critical gap in research, care and awareness, particularly in the Swiss context where data and public dialogue are lacking.
About the project
The project aims to:
- Understand how women perceive and manage perimenopausal symptoms.
- Identify barriers to medical and social support.
- Promote early intervention to reduce chronic health risks.
- Raise awareness through education, podcasts and public events.
- Inform better workplaces about policies and healthcare practices
The impact will be multifaceted: better health literacy, improved well-being and productivity among women and strengthened public and institutional support for this life stage.
Project phases
This participatory, exploratory study will engage 45 women aged 40–50, residing in Switzerland, over a 30-day monitoring period. Data collection and participant interaction will be structured according to the following timeline:
- Design & Ethics Approval (July–August 2025): Finalize study methodology and obtain approval from the ETH Zurich Ethics Commission.
- Participant Recruitment (September–December 2025): Recruit 45 women aged 40–50 via public calls and conduct outreach webinars to inform and onboard participants.
- Data Collection (November–February 2026): Participants will be divided into two-three cohorts. Each group will complete a 30-day period of symptom and lifestyle tracking using a mobile application and wearable device data (Group 1: November 2025, Group 2: January 2026, Group 3: February 2026). Weekly check-ins and optional online workshops will be held during this phase.
- Analysis (March–April 2026): Perform qualitative and quantitative data analysis to identify patterns in symptom perception, behavioral response, and physiological data.
- Dissemination (May–June 2026): Share study outcomes through scientific reports, public presentations, podcast episodes, and awareness events.
Involvement of citizen scientists
The study actively involves 45 citizen participants, who track symptoms, lifestyle habits and emotional states over a 30-day period. Eligible participants will be healthy women aged 40–50, residing in Switzerland. To participate, individuals must also possess a basic wearable tracking device (e.g., smartwatch) and be capable of using a mobile application.
Interested individuals will register online and be invited to an onboarding session, either in person or virtually. During this session, detailed study information will be provided and informed consent will be obtained through a signed participation agreement.
Participants benefit from personalized support, access to exclusive events and materials, and the opportunity to share their stories via podcasts and events. Beyond the core group, the public can participate by engaging in outreach, awareness campaigns, and future discussions. Citizen input is crucial for shaping the study, interpreting results, and ensuring real-world relevance.
